U.S. Markets open in 7 hrs 28 mins
  • S&P Futures

    3,786.25
    -17.00 (-0.45%)
     
  • Dow Futures

    30,237.00
    -128.00 (-0.42%)
     
  • Nasdaq Futures

    11,586.00
    -54.75 (-0.47%)
     
  • Russell 2000 Futures

    1,769.50
    -12.00 (-0.67%)
     
  • Crude Oil

    86.37
    -0.15 (-0.17%)
     
  • Gold

    1,728.80
    -1.70 (-0.10%)
     
  • Silver

    20.85
    -0.24 (-1.16%)
     
  • EUR/USD

    0.9971
    -0.0015 (-0.1496%)
     
  • 10-Yr Bond

    3.6170
    0.0000 (0.00%)
     
  • Vix

    29.07
    -1.03 (-3.42%)
     
  • GBP/USD

    1.1436
    -0.0038 (-0.3328%)
     
  • USD/JPY

    144.1650
    -0.0340 (-0.0236%)
     
  • BTC-USD

    20,190.92
    +572.10 (+2.92%)
     
  • CMC Crypto 200

    457.92
    +12.48 (+2.80%)
     
  • FTSE 100

    7,086.46
    +177.70 (+2.57%)
     
  • Nikkei 225

    27,146.31
    +154.10 (+0.57%)
     

AlerisLife (NASDAQ:ALR) adds US$18m to market cap in the past 7 days, though investors from five years ago are still down 89%

·3 min read

AlerisLife Inc. (NASDAQ:ALR) shareholders will doubtless be very grateful to see the share price up 55% in the last month. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. In fact, the share price has tumbled down a mountain to land 89% lower after that period. While the recent increase might be a green shoot, we're certainly hesitant to rejoice. The fundamental business performance will ultimately determine if the turnaround can be sustained. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.

On a more encouraging note the company has added US$18m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

Check out our latest analysis for AlerisLife

AlerisLife wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually expect strong revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

In the last five years AlerisLife saw its revenue shrink by 34% per year. That puts it in an unattractive cohort, to put it mildly. So it's not altogether surprising to see the share price down 14% per year in the same time period. We don't think this is a particularly promising picture. Of course, the poor performance could mean the market has been too severe selling down. That can happen.

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

earnings-and-revenue-growth
earnings-and-revenue-growth

We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So it makes a lot of sense to check out what analysts think AlerisLife will earn in the future (free profit forecasts).

A Different Perspective

We regret to report that AlerisLife shareholders are down 63% for the year. Unfortunately, that's worse than the broader market decline of 12%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 14% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand AlerisLife better, we need to consider many other factors. To that end, you should be aware of the 3 warning signs we've spotted with AlerisLife .

AlerisLife is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here